Project ECHO HPV Vaccination Series receives support in honor of UNR Med Alumnus John M. Erickson, M.D.

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline. But for ...

At its meeting on Tuesday, the CDC's Advisory Committee on Immunization Practices (ACIP) considered whether the U.S. should ...

Biopharma giant MSD has received approval for its nine-valent HPV (human papillomavirus) vaccine for use in males aged ...

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains l ...

Royal Navy warship HMS Prince of Wales sets sail for Indo-Pacific CNN Anchor Keeps Reporting as 6.2-Magnitude Earthquake ...

A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...

Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of ...

TUNIS/Tunisia Tunis, April 17 (TAP/Meriem Mtiraoui) – the HPV vaccination campaign launched on April 7 for 12-year-old ...

“A US study followed 3,253 women aged 27 to 45 for an average of three and a half years and showed that the vaccine was 88% effective in the prevention of persistent HPV infections, vulval and ...

Within 12 years of the vaccine's introduction in 2006, HPV infections decreased 88 percent among teenage girls and 81 percent among women in their early 20s in the U.S., according to CDC data.